EUVIMEDEUVIMED entdecken
Open Access

Predictive Value of the Oxford Classification for the Effect of Glucocorticoid Therapy in IgA Nephropathy

Sufang Shi iD, Ian S D Roberts iD, Zixuan Wang iD, Lei Jiang iD, Chen Tang iD, Jinwei Wang iD, Jicheng Lv, Muh Geot Wong iD, Sean J Barbour, Vlado Perkovic, Daniel Cattran, Hong Zhang und 1 weitere

Journal of the American Society of Nephrology · 2026-01 · 37 (1) · 150-159

DOI: 10.1681/asn.0000000796 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, online erschienen am 08.07.2025. Verfasst von Sufang Shi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Renal Division, Key Laboratory of Renal Disease, Peking University First Hospital, Peking University Institute of Nephrology, Ministry of Health of C…. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: High Quality Clinical Research Project of Peking University First Hospital, The National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Key Points The presence of cellular segmental sclerosis and crescents predicts a favorable response to glucocorticoid therapy in patients with IgA nephropathy. Glucocorticoid therapy was associated with lower risk of kidney failure across histologic subtypes, with the greatest benefit in cellular segmental sclerosis. The study highlights that there is a need for further subclassification of segmental sclerosis lesions that may guide therapeutic decisions.

Background

The Oxford Classification is widely accepted as a histopathology tool to predict kidney outcomes in IgA nephropathy. However, it remains unclear whether the mesangial hypercellularity (M), endocapillary proliferation (E), segmental glomerulosclerosis (S), tubular atrophy/interstitial fibrosis (T), and crescents (C) scores can predict therapeutic response. This study aims to determine the predictive value of mesangial hypercellularity (M), endocapillary proliferation (E), segmental glomerulosclerosis (S), tubular atrophy/interstitial fibrosis (T), and crescents (C) scores on the efficacy of glucocorticoid therapy using the Therapeutic Effects of Steroids in IgA Nephropathy Global trial.

Methods

Three hundred and seventy-nine Chinese participants were enrolled in the Therapeutic Effects of Steroids in IgA Nephropathy Global trial, of whom 279 had kidney biopsy slides available for central pathology review. The primary outcomes were a composite of ≥40% reduction in eGFR, kidney failure, or death due to kidney disease. Multivariable Cox regression analysis was used to determine the effects of glucocorticoid therapy across pathologic subgroups, and the interaction between glucocorticoid therapy and pathology scores was evaluated.

Results

Among 279 participants selected for this study, the median (interquartile range) time from kidney biopsy to randomization was 4 (3–7) months. The median (interquartile range) follow-up was 4.7 (3.0–6.4) and 5.1 (3.1–6.8) years for the placebo and glucocorticoid-treated group. Glucocorticoid therapy showed benefits across all histologic subtypes. Participants with crescents (C1/C2) showed a trend toward greater benefit from glucocorticoid therapy (C1/2: hazard ratio [HR], 0.05 [95% confidence interval (CI), 0.008 to 0.3]; C0: HR, 0.6 [95% CI, 0.4 to 0.9]; P for interaction = 0.4). Participants with hypercellularity within segmental sclerosis lesions (cellular segmental sclerosis) demonstrated a significant reduction in the risk of kidney failure compared with those without (HR, 0.2 [95% CI, 0.07 to 0.4] versus HR, 0.6 [95% CI, 0.4 to 1.0]; P for interaction = 0.03). Analysis of local pathologists' scores of all 379 Chinese participants demonstrated a significantly greater benefit from glucocorticoid therapy in participants with crescents (C0: HR, 0.7 [95% CI, 0.4 to 1.2]; C1: HR, 0.3 [95% CI, 0.2 to 0.6]; C2: HR, 0.2 [95% CI, 0.08 to 0.7]; P for interaction = 0.05).

Conclusions

The presence of crescents and cellular segmental sclerosis in patients with IgA nephropathy was associated with a favorable response to glucocorticoid therapy.

Schlagwörter

Stichwörter der Autor:innen

IgA nephropathyrenal pathology

Autor:innen und Institutionen

  • Renal Division, Key Laboratory of Renal Disease, Peking University First Hospital, Peking University Institute of Nephrology, Ministry of Health of China, Ministry of Education, Key Laboratory of Chronic Kidney Disease…
  • Oxford University Hospitals, Oxford, United Kingdom.
  • The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
  • The University of Sydney, Sydney, New South Wales, Australia.
  • Department of Renal Medicine, Concord Repatriation General Hospital, Sydney, New South Wales, Australia.
  • Division of Nephrology, The University of British Columbia, Vancouver, British Columbia, Canada.

ORCID-Profile: Sufang Shi, Ian S D Roberts, Zixuan Wang, Lei Jiang, Chen Tang, Jinwei Wang, Muh Geot Wong

Förderung

  • High Quality Clinical Research Project of Peking University First Hospital
  • The National Natural Science Foundation of China

Zitieren

APA

Shi, S., Roberts, I. S. D., Wang, Z., Jiang, L., Tang, C., Wang, J., Lv, J., Wong, M. G., Barbour, S. J., Perkovic, V., Cattran, D., Zhang, H., & TESTING Study Pathology Group (2026). Predictive Value of the Oxford Classification for the Effect of Glucocorticoid Therapy in IgA Nephropathy. Journal of the American Society of Nephrology, 37(1), 150-159. https://doi.org/10.1681/asn.0000000796

Vancouver

Shi S, Roberts ISD, Wang Z, Jiang L, Tang C, Wang J, et al. Predictive Value of the Oxford Classification for the Effect of Glucocorticoid Therapy in IgA Nephropathy. Journal of the American Society of Nephrology. 2026;37(1):150-159. doi:10.1681/asn.0000000796

BibTeX
@article{Shi2026,
  author = {Shi, Sufang and Roberts, Ian S D and Wang, Zixuan and Jiang, Lei and Tang, Chen and Wang, Jinwei and Lv, Jicheng and Wong, Muh Geot and Barbour, Sean J and Perkovic, Vlado and Cattran, Daniel and Zhang, Hong and TESTING Study Pathology Group, TESTING Study Pathology Group},
  title = {Predictive Value of the Oxford Classification for the Effect of Glucocorticoid Therapy in IgA Nephropathy},
  journal = {Journal of the American Society of Nephrology},
  year = {2026},
  volume = {37},
  number = {1},
  pages = {150--159},
  doi = {10.1681/asn.0000000796}
}
Kostenlos starten →